Erin Carter
Director/Board Member at GLUCOTRACK, INC.
Net worth: 41 491 $ as of 2024-04-29
Profile
Erin Carter is currently the Director at GlucoTrack, Inc. Ms. Carter previously worked as the Vice President-Accounting & Reporting at UnitedHealth Group, Inc. Ms. Carter also served as the Assistant Controller at Arterial Vascular Engineering, Inc. Ms. Carter obtained an undergraduate degree from California Polytechnic State University (San Luis Obispo).
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
GLUCOTRACK INC
0.34% | 2024-03-27 | 90,197 ( 0.34% ) | 41 491 $ | 2024-04-29 |
Erin Carter active positions
Companies | Position | Start |
---|---|---|
GLUCOTRACK, INC. | Director/Board Member | 2023-08-24 |
Former positions of Erin Carter
Companies | Position | End |
---|---|---|
Arterial Vascular Engineering, Inc.
Arterial Vascular Engineering, Inc. Medical SpecialtiesHealth Technology Part of Medtronic Plc, Arterial Vascular Engineering, Inc. is a private company that makes a variety of stent systems and balloon angioplasty catheters. The company is based in Santa Rosa, CA. The company was founded by Simon H. Stertzer. Arterial Vascular Engineering was acquired by Medtronic, Inc., part of Medtronic Plc from January 27, 2015 on January 28, 1999 for $3,441.52 million. | Corporate Officer/Principal | 2000-04-30 |
UNITEDHEALTH GROUP INC. | Comptroller/Controller/Auditor | - |
Training of Erin Carter
California Polytechnic State University (San Luis Obispo) | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
GLUCOTRACK, INC. | Health Technology |
UNITEDHEALTH GROUP INC. | Health Services |
Private companies | 1 |
---|---|
Arterial Vascular Engineering, Inc.
Arterial Vascular Engineering, Inc. Medical SpecialtiesHealth Technology Part of Medtronic Plc, Arterial Vascular Engineering, Inc. is a private company that makes a variety of stent systems and balloon angioplasty catheters. The company is based in Santa Rosa, CA. The company was founded by Simon H. Stertzer. Arterial Vascular Engineering was acquired by Medtronic, Inc., part of Medtronic Plc from January 27, 2015 on January 28, 1999 for $3,441.52 million. | Health Technology |
- Stock Market
- Insiders
- Erin Carter